Targeting C3 in autoimmune hemolytic anemias; venetoclax testing to predict AML response; an improved understanding of the structure of FXIII complex
This episode discusses C3-targeted therapy for autoimmune hemolytic anemias, highlighting pegcetacoplan's efficacy, particularly in cold agglutinin disease. It also covers venetoclax sensitivity testing for predicting acute myeloid leukemia response and presents the…